Y. W. Francis Lam

2.2k total citations
74 papers, 1.7k citations indexed

About

Y. W. Francis Lam is a scholar working on Psychiatry and Mental health, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Y. W. Francis Lam has authored 74 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Psychiatry and Mental health, 18 papers in Pharmacology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Y. W. Francis Lam's work include Schizophrenia research and treatment (19 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Electroconvulsive Therapy Studies (9 papers). Y. W. Francis Lam is often cited by papers focused on Schizophrenia research and treatment (19 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Electroconvulsive Therapy Studies (9 papers). Y. W. Francis Lam collaborates with scholars based in United States, Taiwan and China. Y. W. Francis Lam's co-authors include Larry Ereshefsky, Michael W. Jann, Charlotte Davis, Cara L. Alfaro, Joseph R. Simpson, Robert L. Talbert, Shireen Banerji, Michael Miller, Wei‐Hau Chang and Dawn I. Velligan and has published in prestigious journals such as JAMA, Biological Psychiatry and Psychopharmacology.

In The Last Decade

Y. W. Francis Lam

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. W. Francis Lam United States 21 555 545 332 300 191 74 1.7k
Norio Yasui‐Furukori Japan 29 602 1.1× 521 1.0× 347 1.0× 414 1.4× 229 1.2× 133 2.4k
Richard F. Bergstrom United States 23 978 1.8× 383 0.7× 562 1.7× 246 0.8× 175 0.9× 41 2.0k
Jürgen Schmider United States 27 514 0.9× 1.0k 1.9× 410 1.2× 303 1.0× 249 1.3× 29 2.6k
L. P. Balant Switzerland 23 411 0.7× 380 0.7× 364 1.1× 232 0.8× 241 1.3× 51 1.7k
Joseph C. Fleishaker United States 27 538 1.0× 381 0.7× 462 1.4× 244 0.8× 327 1.7× 85 2.1k
Maria Gabriella Scordo Italy 25 914 1.6× 1.0k 1.9× 470 1.4× 386 1.3× 219 1.1× 32 2.1k
Kazuo Mihara Japan 24 989 1.8× 589 1.1× 343 1.0× 333 1.1× 216 1.1× 89 1.6k
Juan Antonio Carrillo Spain 24 376 0.7× 831 1.5× 478 1.4× 247 0.8× 383 2.0× 54 2.0k
Peter J. Wedlund United States 17 415 0.7× 763 1.4× 203 0.6× 276 0.9× 258 1.4× 39 1.4k
Pedro Dorado Spain 26 360 0.6× 1.3k 2.3× 340 1.0× 335 1.1× 255 1.3× 83 1.9k

Countries citing papers authored by Y. W. Francis Lam

Since Specialization
Citations

This map shows the geographic impact of Y. W. Francis Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. W. Francis Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. W. Francis Lam more than expected).

Fields of papers citing papers by Y. W. Francis Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. W. Francis Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. W. Francis Lam. The network helps show where Y. W. Francis Lam may publish in the future.

Co-authorship network of co-authors of Y. W. Francis Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Y. W. Francis Lam. A scholar is included among the top collaborators of Y. W. Francis Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. W. Francis Lam. Y. W. Francis Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Y. W. Francis, Rogier V. Immink, Jimmy Schenk, et al.. (2025). The role of blood pressure versus oxygen administration on cerebral oxygenation during and after anaesthesia induction. European Journal of Anaesthesiology. 43(3). 226–234.
2.
Tong, Christopher, et al.. (2025). Rapid microbial evaluation of acute exacerbations of bronchiectasis using FilmArray Pneumonia plus Panel in a real-world setting. Therapeutic Advances in Respiratory Disease. 19. 2703921079–2703921079. 1 indexed citations
3.
Cheung, Tan To, Simon C.H. Yu, Stephen L. Chan, et al.. (2022). The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021. HepatoBiliary Surgery and Nutrition. 12(3). 366–385. 7 indexed citations
4.
Lam, Y. W. Francis. (2022). Alprazolam safety in pregnancy. 34(2). 2–3.
5.
Lam, Y. W. Francis. (2021). Polypharmacy in clozapine‐treated patients. 32(5). 2–3. 1 indexed citations
6.
Lam, Y. W. Francis. (2019). Drugs and QT interval prolongation in patients with PTSD. 30(2). 2–3. 1 indexed citations
7.
Lam, Y. W. Francis. (2018). Antipsychotic‐associated urinary tract infections in the elderly. 29(10). 2–3. 1 indexed citations
8.
Lam, Y. W. Francis. (2016). Cognitive effects of second‐generation antidepressants in the elderly. 27(7). 2–3. 1 indexed citations
9.
Lam, Y. W. Francis, Larry Ereshefsky, Andreas Port, C. J. Timmer, & Peter Dogterom. (2009). Effects of Rifampin on the Disposition of Gepirone ER and Its Metabolites. 3. 1–7. 3 indexed citations
10.
Desai, H G, et al.. (2001). Lack of CYP3A4 Inhibition by Grapefruit Juice and Ketoconazole upon Clozapine Administration in Vivo. Drug metabolism and drug interactions. 18(3-4). 263–278. 10 indexed citations
11.
Alfaro, Cara L., Y. W. Francis Lam, Joseph R. Simpson, & Larry Ereshefsky. (1999). CYP2D6 Status of Extensive Metabolizers After Multiple-Dose Fluoxetine, Fluvoxamine, Paroxetine, or Sertraline. Journal of Clinical Psychopharmacology. 19(2). 155–163. 66 indexed citations
12.
Lam, Y. W. Francis, et al.. (1996). Intraindividual Variability of the Dextromethorphan/Dextrorphan (DM/DP) Ratio in Extensive Metabolizers. Clinical Pharmacology & Therapeutics. 59(2). 137–137. 6 indexed citations
13.
Ereshefsky, Larry, et al.. (1995). Antidepressant Drug Interactions and the Cytochrome P450 System. Clinical Pharmacokinetics. 29(Supplement 1). 10–19. 118 indexed citations
14.
Jann, Michael W., et al.. (1994). Formation of Reduced Haloperidol after Intramuscular Haloperidol Administration in Schizophrenic Patients. Clinical Drug Investigation. 7(1). 18–25. 2 indexed citations
15.
Lam, Y. W. Francis, et al.. (1993). Sensitive high-performance liquid chromatographic assay for the determination of chlorhexidine in saliva. Journal of Chromatography B Biomedical Sciences and Applications. 612(1). 166–171. 24 indexed citations
16.
Lam, Y. W. Francis, et al.. (1993). Hypoxia, Arterial pH and Theophylline Disposition. Clinical Pharmacokinetics. 25(4). 283–299. 16 indexed citations
17.
Lam, Y. W. Francis, et al.. (1991). Effect of Probenecid on the Pharmacokinetics and Pharmacodynamics of Procainamide. The Journal of Clinical Pharmacology. 31(5). 429–432. 5 indexed citations
18.
Jann, Michael W., et al.. (1989). Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients. Biological Psychiatry. 26(3). 239–249. 35 indexed citations
19.
Lam, Y. W. Francis, et al.. (1989). Pharmacokinetics of Haloperidol. Clinical Pharmacokinetics. 17(6). 396–423. 251 indexed citations
20.
Lam, Y. W. Francis, et al.. (1986). Alcium Channel Blockers and Treatment of Hypertension. Drug Intelligence & Clinical Pharmacy. 20(3). 187–198. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norio Yasui‐Furukori Breakdown of academic impact, for papers by Richard F. Bergstrom Breakdown of academic impact, for papers by Jürgen Schmider Breakdown of academic impact, for papers by L. P. Balant Breakdown of academic impact, for papers by Joseph C. Fleishaker Breakdown of academic impact, for papers by Maria Gabriella Scordo Breakdown of academic impact, for papers by Kazuo Mihara Breakdown of academic impact, for papers by Juan Antonio Carrillo Breakdown of academic impact, for papers by Peter J. Wedlund Breakdown of academic impact, for papers by Pedro Dorado
Rankless by CCL
2026